Primary Site >> Colorectal Cancer
Gene >> CERS5
|
|
|
|
|---|---|---|---|
|
Ref: De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation. PMID: 18400537 |
Ref: Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer. PMID: 19828471 |
Ref: Linking the ceramide synthases (CerSs) 4 and 5 with apoptosis, endometrial and colon cancers. PMID: 25779024 Ref: Endocannabinoid and ceramide levels are altered in patients with colorectal cancer. PMID: 25975960 Ref: High CerS5 expression levels associate with reduced patient survival and transition from apoptotic to autophagy signalling pathways in colorectal cancer. PMID: 27499893 |
Ref: Chemosensitivity of human colon cancer cells is influenced by a p53-dependent enhancement of ceramide synthase 5 and induction of autophagy. PMID: 30059758 Ref: Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer. PMID: 30272337 |